Akhtar Ashfaq, MD
Dr. Ashfaq is an Internist and Nephrologist by training and is board certified in both internal medicine and nephrology. After finishing medical school, Dr. Ashfaq did his internal medicine internship and residency at Good Samaritan Hospital, University of Cincinnati in Cincinnati, Ohio, where he was also a Chief Resident. He then joined North Shore University Hospital, Cornell University School of Medicine for fellowship in Nephrology.
After completing fellowship, he joined a private practice in Lewistown, Pennsylvania for a short time. In 1997, Dr. Ashfaq was appointed on the faculty of North Shore University Hospital and then on the faculty of NS-LIJ Health System, Albert Einstein College of Medicine. During this time, he served as Associate Program Director of Nephrology fellowship program, Director of Inpatient Services and Director of Clinical trials. In 2005, Dr. Ashfaq was appointed as Associate Chief Division of Nephrology and he stayed on this position until April of 2009. During the time in Academia, he also served on the faculty of Cornell University Medical College and NYU School of Medicine and Hofstra University School of Medicine, a position he still holds. When he left Academia; he joined Amgen Inc. as Clinical Research Medical Director where he led North American medical teams for Epogen and Aranesp.
In addition, he was Medical Lead for policy, strategy and advocacy for nephrology franchise. He also represented Amgen on Kidney Care Partners, a coalition of several stakeholders, serving nephrology community. In 2015, Dr. Ashfaq moved to Astra Zeneca to start the CKD group in Global Medical Affairs. In that capacity, he laid the foundation of CKD franchise and was instrumental in preparing Astra Zeneca for the global launches of two potential blockbuster molecules in the areas of Anemia and Hyperkalemia.
During his career, Dr. Ashfaq has published in Major Nephrology Journals, has contributed to Internal Medicine and Nephrology text books; he has been a reviewer for most of the Nephrology journals and also served as a reviewer of NephSAP. He has also been on the editorial board of Journal of Nephrology. He has received many teaching awards. He was also the founder of Long Island chapter of polycystic kidney disease foundation. In addition Dr. Ashfaq has been on the board of trustees of American Kidney fund and is also an active member of the Medical Advisory Board of American Association of Kidney Patients.
His major area of interest is patient awareness and education and improving the life of patients with chronic kidney disease.